Takeda Pharmaceutical Company Limited Profit Loss Attributable To Noncontrolling Interests
Takeda Pharmaceutical Company Limited (TAK) reported Profit Loss Attributable To Noncontrolling Interests of JPY 215.00 million for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:ProfitLossAttributableToNoncontrollingInterests · last filed 2025-06-25
| Period end | Profit Loss Attributable To Noncontrolling Interests 12 month |
|---|---|
| 2025-03-31 | 215.00M JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 130.00M JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 21.00M JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 107.00M JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 166.00M JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 49.00M JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | -112.00M JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | -178.00M JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 573.00M JPY 20-F · filed 2019-06-27 |